These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1653586)
1. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Hoosein NM; Boyd DD; Hollas WJ; Mazar A; Henkin J; Chung LW Cancer Commun; 1991 Aug; 3(8):255-64. PubMed ID: 1653586 [TBL] [Abstract][Full Text] [Related]
2. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Hollas W; Hoosein N; Chung LW; Mazar A; Henkin J; Kariko K; Barnathan ES; Boyd D Thromb Haemost; 1992 Dec; 68(6):662-6. PubMed ID: 1337629 [TBL] [Abstract][Full Text] [Related]
3. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. Hudson MA; McReynolds LM J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186 [TBL] [Abstract][Full Text] [Related]
4. Androgen induction of urokinase gene expression in LNCaP cells is dependent on their interaction with the extracellular matrix. Pentyala SN; Whyard TC; Waltzer WC; Meek AG; Hod Y Cancer Lett; 1998 Aug; 130(1-2):121-6. PubMed ID: 9751264 [TBL] [Abstract][Full Text] [Related]
5. Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines. Lyon PB; See WA; Xu Y; Cohen MB Prostate; 1995 Oct; 27(4):179-86. PubMed ID: 7479384 [TBL] [Abstract][Full Text] [Related]
6. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells. Waghray A; Webber MM Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041 [TBL] [Abstract][Full Text] [Related]
7. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells. Wilson MJ; Sinha AA Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650 [TBL] [Abstract][Full Text] [Related]
8. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines. Hudson MA; McReynold LM Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442 [TBL] [Abstract][Full Text] [Related]
10. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Boyd D; Florent G; Kim P; Brattain M Cancer Res; 1988 Jun; 48(11):3112-6. PubMed ID: 2835152 [TBL] [Abstract][Full Text] [Related]
11. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760 [TBL] [Abstract][Full Text] [Related]
12. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Webber MM; Waghray A Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042 [TBL] [Abstract][Full Text] [Related]
13. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms. Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599 [TBL] [Abstract][Full Text] [Related]
15. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Reile H; Armatis PE; Schally AV Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709 [TBL] [Abstract][Full Text] [Related]
16. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Thomas S; Chiriva-Internati M; Shah GV Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556 [TBL] [Abstract][Full Text] [Related]
17. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Liu G; Shuman MA; Cohen RL Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264 [TBL] [Abstract][Full Text] [Related]
18. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686 [TBL] [Abstract][Full Text] [Related]
19. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Siu SW; Lau KW; Tam PC; Shiu SY Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702 [TBL] [Abstract][Full Text] [Related]
20. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Mohanam S; Sawaya R; McCutcheon I; Ali-Osman F; Boyd D; Rao JS Cancer Res; 1993 Sep; 53(18):4143-7. PubMed ID: 8395977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]